Literature DB >> 31760238

Clinicopathological complexity in the application of the universal definition of myocardial infarction.

Louis Maximilian Buja1, Bradley Zehr2, Laura Lelenwa3, Eze Ogechukwu2, Bihong Zhao3, Amitava Dasgupta3, Rolf F Barth2.   

Abstract

A universal definition of myocardial infarction (UDMI) has been established, periodically updated, and refined over the past twenty years. The primary purpose of the UDMI is to bring uniformity and accuracy to clinical diagnosis. Herein, a review and analysis of the UDMI is presented with emphasis on clinicopathological correlation. Determination of the presence of myocardial injury is based on the detection of abnormal serum cardiac biomarkers, particularly cardiac troponin (cTn), and in the current fourth iteration of the UDMI, high sensitivity (hs)-cTn. Differentiation of myocardial infarction from other causes of myocardial injury requires the documentation of clinical evidence of myocardial ischemia. In this review, difficulties in applying the UDMI in actual practice are discussed, based on the experience and perspective of those of us who face these problems as part of our own practice of pathology. The complexity in application of the UDMI is highlighted by the presentation of five illustrative cases involving the differential diagnosis of myocardial injury and myocardial infarction due to atherothrombotic and nonatherothrombotic coronary artery disease. The cases include myocardial infarction due to severe coronary atherosclerosis, supply-demand mismatch, coronary artery dissection associated with an eosinophilic coronary periarteritis, and coronary thromboembolism, and a case with a differential diagnosis of myocarditis and myocardial infarction. These cases illustrate how pathological findings can contribute to more accurate application of the UDMI and how, when critically applied, the UDMI can be used to better characterize myocardial infarcts in clinical practice.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute coronary syndromes; Coronary artery dissection; Eosinophilic periarteritis; Myocardial infarction; Myocardial injury; Myocarditis; Pathology; Troponin; Universal definition

Mesh:

Substances:

Year:  2019        PMID: 31760238     DOI: 10.1016/j.carpath.2019.107153

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  8 in total

1.  miRNA-29 aggravates myocardial infarction via inhibiting the PI3K/mTOR/HIF1α/VEGF pathway.

Authors:  Xiaoxi Wang; Yanning Liu; Huiqing Hou; Weihua Shao; Dai Huang; Zhihua Hao; Hongyuan Xue; Yuquan Ye
Journal:  Aging (Albany NY)       Date:  2022-04-04       Impact factor: 5.682

2.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

3.  The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities.

Authors:  Louis Maximilian Buja; Dwayne A Wolf; Bihong Zhao; Bindu Akkanti; Michelle McDonald; Laura Lelenwa; Noah Reilly; Giulia Ottaviani; M Tarek Elghetany; Daniel Ocazionez Trujillo; Gabriel M Aisenberg; Mohammad Madjid; Biswajit Kar
Journal:  Cardiovasc Pathol       Date:  2020-05-07       Impact factor: 2.185

Review 4.  Recent updates on COVID-19: A holistic review.

Authors:  Shweta Jakhmola; Omkar Indari; Dharmendra Kashyap; Nidhi Varshney; Annu Rani; Charu Sonkar; Budhadev Baral; Sayantani Chatterjee; Ayan Das; Rajesh Kumar; Hem Chandra Jha
Journal:  Heliyon       Date:  2020-12-11

Review 5.  Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.

Authors:  Yong-Jian Geng; Zhi-Yao Wei; Hai-Yan Qian; Ji Huang; Robert Lodato; Richard J Castriotta
Journal:  Cardiovasc Pathol       Date:  2020-04-17       Impact factor: 2.185

Review 6.  Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019.

Authors:  Vineeta Tanwar; Jeremy M Adelstein; Loren E Wold
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 10.787

Review 7.  Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment.

Authors:  Wei Zhu; Zhanqi Wei; Chang Han; Xisheng Weng
Journal:  Nanomaterials (Basel)       Date:  2021-12-10       Impact factor: 5.076

8.  Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Carry MicroRNA-671 to Alleviate Myocardial Infarction Through Inactivating the TGFBR2/Smad2 Axis.

Authors:  Xue Wang; Yuhai Zhu; Chengcheng Wu; Wennan Liu; Yujie He; Qing Yang
Journal:  Inflammation       Date:  2021-04-21       Impact factor: 4.092

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.